Patient outcomes

Helping close the gap in cancer survivorship through enhanced diagnostics

March 2016

Share to Twitter Share to Facebook Share to LinkedIn Send by email

Over the next 9 years, the Molecular Imaging Collaborative Network (MICN), led by Alliance Medical, is delivering PET-CT services to 60% of England under a new National Contract.  

This contract will bring local access to patients across the country to these cutting-edge diagnostics, addressing the historic inequalities and variations in access.

In 2015, Alliance Medical formed a unique partnership with The Christie NHS Foundation Trust (the largest cancer centre in Europe) together with other NHS hospitals, patient representatives, academic centres, charities and commissioners to deliver a transformational programme of PET-CT services under the new National Contract.  This partnership has a shared purpose of improving cancer survival rates above the current 54% by 2025 and has been widely acknowledged as an exemplar of how the independent sector supports the future of the NHS.

PET-CT is one of the most powerful imaging tools available to clinicians today in the diagnosis and staging of cancer and increasingly other conditions such as cardiac and neurological diseases.  Since 2008, the NHS has focused on increasing access to this important modality, however, the constant demand for local level capacity has resulted in gaps in the service.   In some areas there is still a substantial gap between the number of patients who would be expected to receive a scan and those who actually do – and the UK lags behind Europe in terms of access to PET-CT scans.   This is one of the reasons why people with cancer are typically diagnosed later than in many European countries – and that our 5-year survival rates are just 54% compared with 67% on average in many developed European healthcare systems.1


As part of the MICN partnership, Alliance Medical is currently upgrading the national PET-CT infrastructure with new static scanners replacing mobile units and 5 completely new sites.

98% of people will be within a one-hour drive of a static scanner by February 2016 (subject to planning)


Improved local access to a new generation of PET-CT scanners, together with enhanced processes, will contribute to even earlier and more accurate diagnoses – and increased survivorship.  At the same time, the travel time and distance is reduced for many patients.

… we should set ourselves the achievable target of raising our cancer survival rates to match the very best in Europe … the key is faster diagnosis
Professor Sir Bruce Keogh
National Medical Director, NHS England Backs Cancer Campaign,, March 2014

To discuss your own specific imaging needs, please contact us.


Read more of our partnership case studies

AML Quality Account 2020/21

The report has now been finalised and is ready for download


View profiles of our UK Board and Management Team

Our story

Learn more about our history and growth


Corporate governance and quality assured service excellence

Alliance Medical are Europe’s leading independent provider of medical imaging services. 

We combine service excellence and innovative imaging technologies to improve patient care and support NHS and independent sector organisations with their ongoing imaging requirements. Our approach has delivered consistent company growth for more than 25 years.


Close menu

Current vacancies

Visit our jobs site to view latest vacancies, register as a candidate and apply for jobs.

Search vacancies now

Carrying out over 2 million scans per year, we set our standards high when it comes to our people and their careers. Investment in integrated systems and individual expertise allows the development of services and long term partnerships to be forged which has seen us grow to be the imaging healthcare provider of choice for patients, referrers and employees.
Quality, safety and transparency underpin all the we do.
Close menu

Alliance Medical is Europe’s leading diagnostic and molecular imaging services provider delivering high quality diagnostic solutions in partnership with public organisations.  

We form an effective part of the health economy in each of the countries in which we operate and see our role as supporting the existing healthcare infrastructure, providing innovative partnership solutions to address local challenges in a way that builds on the strengths of existing core services.

Close menu